BMY
Bristol-Myers Squibb Co
Price:  
56.28 
USD
Volume:  
12,048,155.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Bmy WACC - Weighted Average Cost of Capital

The WACC of Bristol-Myers Squibb Co (BMY) is 6.3%.

The Cost of Equity of Bristol-Myers Squibb Co (BMY) is 7.20%.
The Cost of Debt of Bristol-Myers Squibb Co (BMY) is 4.40%.

Range Selected
Cost of equity 6.00% - 8.40% 7.20%
Tax rate 16.00% - 22.80% 19.40%
Cost of debt 4.00% - 4.80% 4.40%
WACC 5.3% - 7.2% 6.3%
WACC

Bmy WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.47 0.63
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.00% 8.40%
Tax rate 16.00% 22.80%
Debt/Equity ratio 0.33 0.33
Cost of debt 4.00% 4.80%
After-tax WACC 5.3% 7.2%
Selected WACC 6.3%